计算溶液所需的质量、体积或浓度。
AZD1897 is a PIM1 , PIM2 , and PIM3 inhibitor with IC 50 values of less than 3 nM for these three PIM kinases. AZD1897 exhibits anticancer activity and synergistically inhibits the activity of acute myeloid leukemia (AML) cells in combination with Capivasertib. This synergistic inhibitory effect is achieved through the inhibition of the mTOR and MCL1 pathways.